Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 – 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy® – Yahoo Finance

Industry presentation on July 13, 2022: "Enabling lung cancer screening with iBiopsy® AI-based software as medical device"
Scientific paper presentation on July 15, 2022: "Development and validation of a machine learning based CADx designed to improve patient management in lung cancer screening programmes"
Median will present the latest developments on iBiopsy® LCS CADe/CADx¹ Software as Medical Device (SaMD) at Booth #AI-29, Expo X1, AI-area
SOPHIA ANTIPOLIS, France, July 08, 2022–(BUSINESS WIRE)–Regulatory News:
Median Technologies (ALMDT) (Paris:ALMDT) announced today that the Company will be participating in the 2022 European Congress of Radiology (ECR), to be held in Vienna, Austria, July 13-17.
The Company will give an industry presentation and a scientific paper presentation. Details of the sessions include:
Industry presentation: "Enabling lung cancer screening with iBiopsy® AI-based software as medical device"
Session: AIX Theater
Date: July 13, 2022
Time: 3:25 pm – 3:45 pm CEST
Scientific paper presentation: RPS 1305-6 – "Development and validation of a machine learning based CADx designed to improve patient management in lung cancer screening programmes"
Session: RPS 1305 – Artificial intelligence (AI) in chest imaging: part 2
Categories: Artificial Intelligence & Machine Learning, Imaging Informatics, Chest, Oncologic Imaging
Date: July 15, 2022
Time: 10:30 am – 12:00 pm CEST
Median’s team will be available at booth #AI-29, Expo X1, AI-area to discuss the presentations and present the latest developments on iBiopsy® LCS CADe/CADx SaMD from July 13 to 17, 9:00 am-5:00 pm.
The European Congress of Radiology (ECR) organized by the European Society of Radiology (ESR) is the premier European event in radiology and the second largest in the world. The congress conveys more than 20,000 with a split of more than 10,000 professional delegates (radiologists, technologists etc.), and ~8,000 industry participants (imaging modalities, PACS etc.). Radiology professionals from Europe and beyond attend to gather knowledge through educational courses, to see the latest innovations presented by technical exhibitors, and to discover groundbreaking research from scientific paper presentations. More about the ECR: https://www.myesr.org/congress
About iBiopsy®: iBiopsy® is based on the most advanced technologies in Artificial Intelligence (AI) and Data Science (DS), benefiting from Median’s expertise in medical image processing. iBiopsy® targets the development of innovative AI/ML-based Software as Medical Device, to be used in several indications for which there are unmet needs regarding early diagnosis, prognosis and treatment selection in the context of precision medicine. iBiopsy® currently focuses on lung cancer, liver cancer (HCC) and liver fibrosis (NASH).
About Median Technologies: Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy®, our AI-powered software as medical device help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label "Innovative company" by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME), is part of the Enternext® PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: www.mediantechnologies.com
¹ A radiological CADe device is "intended to identify, mark, highlight or otherwise direct attention to portions of an image that may reveal abnormalities during interpretation of images by the clinician." A CADx device is "intended to provide information beyond identifying abnormalities, such as an assessment of disease." Source: FDA
View source version on businesswire.com: https://www.businesswire.com/news/home/20220708005258/en/
Contacts
Median Technologies
Emmanuelle Leygues
Head of Corporate Marketing & Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press – ALIZE RP
Caroline Carmagnol
+33 6 64 18 99 59
median@alizerp.com
Investors – ACTIFIN
Ghislaine Gasparetto
+33 6 21 10 49 24
ggasparetto@actifin.fr
Related Quotes
The pharmaceutical company’s earnings could double over coming years on the success of new drug treatments.
Pfizer shared encouraging clinical trial results for a drug candidate focused on treating a form of inflammatory bowel disease.
In Plano, Texas, a pregnant woman plans to fight a $275 fine after she was given a ticket for driving in a HOV lane alone, citing her unborn child as her passenger.
As epidemics go, the monkeypox outbreak should have been relatively easy to snuff out. The virus does not spread efficiently except through intimate contact, and tests and vaccines were at hand even before the current outbreak. Yet the response in the United States has been sluggish and timid, reminiscent of the early days of the COVID pandemic, experts say, raising troubling questions about the nation’s preparedness for pandemic threats. The first cases of monkeypox were reported in May, but te
Representative Alexandria Ocasio-Cortez (D., N.Y.) provided an excuse for the targeting of Justice Brett Kavanaugh while he dined at Morton's Steakhouse's downtown location in Washington, D.C. on Wednesday evening.
In her memoir, the "Spy Kids" actress wrote about how five years of binging and purging caused significant damage to her body.
Both new subvariants, BA.2.75 and BA.5.3.1, have been identified in the U.S., the Centers for Disease Control and Prevention told Fortune this week.
WASHINGTON (Reuters) -A U.S. congressional committee has asked data brokers and personal health apps to explain how they handle users' reproductive health data amid concerns states will use the information to track patients seeking abortion where it is illegal. Democrats on the House of Representatives Oversight Committee said they were concerned that location data, search history and other information on mobile phones could create "digital bread crumbs" that reveal interest in an abortion. "The collection of sensitive data could pose serious threats to those seeking reproductive care," the lawmakers wrote on Friday.
You can avoid common running overuse injuries, including plantar fasciitis, Achilles tendinitis and shin splints, if you spend time stretching and strengthening the muscles in your ankles and feet, she says. “If you don’t have healthy foot and ankle mechanics, you feel it up the body chain,” says Dr. Trotter, who practices in Little Silver, N.J. “It can affect balance and lead to knee, back and hip pain.” Dr. Trotter sees an uptick of patients each summer as many switch to flip-flops.
Addison Bethea, 17, is on the road to recovery after suffering serious injuries in a shark attack late last month
Alex Wong/Getty ImagesThe White House tried to defend President Joe Biden’s seemingly drowsy response to the reversal of Roe v Wade on Saturday but instead sparked instant backlash by labeling pro-choice activists “out of touch.”The apparent jab was made in a statement to The Washington Post responding to criticism of what many Democrats see as a response that has been too little, too late. White House communications director Kate Bedingfield said: “The president has been showing his deep outrag
The 33-year-old man, identified only by his pseudonym Chen Li to protect his identity, was initially diagnosed with appendicitis after complaining of abdominal discomfort and blood in his urine, according to South China Morning Post. Despite being treated for appendicitis, Chen’s symptoms persisted. After traveling some 930 miles from Sichuan province to Guangzhou to visit a hospital that treats genitalia issues, Chen discovered through medical examination that he also had female reproductive organs, such as a uterus and ovaries.
The BA.5 subvariant of COVID-19's omicron variant is the dominant strain in Louisville's wastewater, data from June 30 shows.
"Here is my appeal for more information for women, more general interest in taking care of the female body so that we can be free and be able to take care of ourselves," Anitta posted on social media
The measure, which officials have long warned was on the table, could go into effect as soon as late July.
For many people around the U.S., it might very well seem as though the worst of COVID is over. After all, both virus-related case and death counts are falling, according to the Centers for Disease Control and Prevention (CDC). The agency's latest data shows that infections are down by nearly 4 percent this week compared to last and deaths have dropped by more than 20 percent. But this is hardly the first time we've seen COVID numbers decline in the last two years before shooting back up. Another
The $20 million will be used to accelerate three ongoing clinical trials by the company for Covid-19 vaccines and cancer treatments. In January, GeoVax raised $10 million for the same clinical trials.
California will start making its own affordable insulin as part of an effort to combat high drug prices for a lifesaving medication that's been made inaccessible for some Americans living with diabetes, Democratic Gov. Gavin Newsom announced Thursday. Newsom said in a video posted to Twitter that $100 million from the state budget he recently signed for 2022-2023 would be allocated for California to "contract and make [its] own insulin at a cheaper price, close to at cost, and to make it availab
Las Vegas mom Eliana Rodriguez says her big baby bump drew public fascination.
According to the Centers for Disease Control and Prevention, "Every 40 seconds, someone in the United States has a stroke. Every 3.5 minutes, someone dies of stroke. The CDC adds, "Every year, more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes. About 185,000 strokes—nearly 1 in 4—are in people who have had a previous stroke. About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked." So what exactly is a s

source